Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STRAP-EU biopsy-driven biologic stratification trial in rheumatoid arthritis
2017-004079-30Phase 3Completed
- Sponsor
- Joint Research & Development Office
- Start
- Feb 2018
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in rheumatoid arthritis (RA) comparing MabThera, RoActemra and Enbrel (3 arms). Primary endpoint: ACR20 response at 16 weeks in B-cell poor pathotype subgroup. Started Feb 2018; status: completed.
02
Drugs
rituximabtocilizumabetanercept
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2017-004079-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-004079-30.